Our history

2011
August Acquisition of Enzimas S.A.
April Acquisition of Robert & Fils
2010
December Acquisition of Seroyal
March Acquisition of Trophic Canada
February Alcrea Health is launched – experts in product design and manufacturing of health products using the art of science and innovation
2009
September Acquisition of Garden of Life
January Acquisition of the Wobenzym® family of products manufacturing facility (EAB)
2008
December Acquisition of Nutri-Health and its family of brands
September Acquisition of the AOV brand (Orthos Europe BV)
May Atrium Innovations divests its Active Ingredients & Specialty Chemicals Division
February Acquisition of Orthica and its family brands (Multicare BV)
2007
July Acquisition of Wobenzym® and its family of brands (Mucos Emulsions GMBH)
June Pierre Fitzgibbon appointed as President and CEO
May Atrium Biotechnologies changes its name to Atrium Innovations
January Acquisition of a liquid-filled capsule manufacturing facility (AquaCap) and its Caplique technology
2006
October Atrium Biotechnologies is spun-off
September Acquisition of Douglas Laboratories Canada
2005
December Acquisition of Douglas Laboratories
March Atrium becomes a publicly-traded company with an Initial Public Offering
2004
March Acquisition of Pure Encapsulations
2000
Two private placements with SGF Soquia Inc. and Fonds de solidarité des travailleurs du Québec (FTQ)
1999
December Atrium Innovations is established as a separate subsidiary of Æterna Zentaris. Both companies where founded by brothers, Eric and Luc Dupont.